Print

Vernalis PLC (VNLS) Signs Agreement With Diosynth Biotechnology (Research Triangle Park) For Phase III Manufacture Of V10153 
10/19/2005 5:12:29 PM

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Sept. 22, 2005--Vernalis Plc has signed a contract with Diosynth Biotechnology for process development, scale-up and manufacturing of V10153 for Phase III clinical trials.
//-->